Any tools for predicting binding affinity between TCR and epitode?
3
1
Entering edit mode
5.9 years ago
CY ▴ 750

I am working on a immunotherapy related project that identify tumor epitode (neiantigen) and TCR-seq. Say I already have both epitode and sequences of T/B cell CDR3 region available. Is there any tools available for predicting their binding affinity?

prediction TCR cancer • 3.9k views
ADD COMMENT
1
Entering edit mode
5.5 years ago
niuyw ▴ 40

Hi! I found these tools by Google, but I haven't try any of them. Hope to be helpful.

  • OncoPeptVAC: a robust TCR binding algorithm to prioritize neoepitope using tumor mutation (DNAseq) and gene expression (RNAseq) data.
  • TCRex: a webtool for the prediction of T-cell receptor sequence epitope specificity.
  • NetTCR: sequence-based prediction of TCR binding to peptide-MHC complexes using convolutional neural networks.
  • Repitope: epitope immunogenicity prediction through in silico TCR-peptide contact potential profiling.
ADD COMMENT
0
Entering edit mode
5.9 years ago
igor 13k

I am not too familiar with this type of analysis, but IEDB Analysis Resource may be what you are looking for:

Welcome to the Immune Epitope Database Analysis Resource. This site provides a collection of tools for the prediction and analysis of immune epitopes. It serves as a companion site to the Immune Epitope Database (IEDB) , a manually curated database of experimentally characterized immune epitopes.

ADD COMMENT
0
Entering edit mode

I believe that IEDB predicts MHC - epitope binding. Not epitope - TCR binding which is the next step once the epitope got presented to the cell surface.

ADD REPLY
0
Entering edit mode

Thanks for clarifying.

IEDB has a lot of different tools, so I assumed they covered the full range. Maybe not.

ADD REPLY
0
Entering edit mode
9 weeks ago
tim • 0

Hi! If you still need help with your problem, one of the leading tools to determine the epitope specificity of your T-cell receptor sequences is IMW-DETECT. If you want to know how powerful those bindings are. We don't have that solution, but by running our tool, we can help to filter out less specific TCRs or false-positive TCRs. We are running a free access through immunewatch.com/detect-early-access-program/. Disclosure, I am working on the product.

ADD COMMENT

Login before adding your answer.

Traffic: 2101 users visited in the last hour
Help About
FAQ
Access RSS
API
Stats

Use of this site constitutes acceptance of our User Agreement and Privacy Policy.

Powered by the version 2.3.6